Caricamento...

Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis

BACKGROUND: Tamoxifen was recommended by NICE in 2013 for chemoprevention of breast cancer, but a recent survey suggested only a quarter of GPs are aware of this. We set out to measure the uptake of tamoxifen, and the alternative raloxifene, in national prescribing data sets. METHODS: Tamoxifen and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Cancer
Autori principali: Curtis, Helen J., Walker, Alex J., Goldacre, Ben
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943266/
https://ncbi.nlm.nih.gov/pubmed/29681615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0065-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !